- Professor, Global Health
- Professor, Pharmacy
- Adjunct Professor, Epidemiology
- Adjunct Professor, Health Metrics Sciences
- Associate Dean, School of Pharmacy
Select from the following:
Dr. Stergachis’ research and teaching focuses primarily on the safety and use of medicines and vaccines in LMICs. He is Associate Dean for Research and Graduate Programs in the School of Pharmacy, Director of the Global Medicines Program and Director of the Biomedical Regulatory Affairs Program. He directed a pharmacovigilance pregnancy registry study on the safety of first trimester antimalarials conducted in three sub-Saharan African countries and has developed novel approaches for HIV pharmacovigilance and strengthening pharmacy services in LMICs. His interests also include antimicrobial resistance and antimicrobial stewardship. He is an elected member of the National Academy of Medicine, having served on numerous committees. Previously, he was senior advisor to the Bill & Melinda Gates Foundation Safety Surveillance Working Group, a member of the US FDA Drug Safety and Risk Management Advisory Committee, and Chair of the Malaria in Pregnancy Consortium Safety Working Group. He is a Fellow of the American Pharmacists Association and of the International Society for Pharmacoepidemiology.
- PhD (University of Minnesota)
- MS (University of Minnesota)
- BPharm (Washington State University)
- Greek
- Biodefense Infectious Diseases
- Burden of Disease
- Drug and Vaccine Development
- Education and Training
- Health Outcomes
- Health Technologies
- HIV/AIDS
- Immunizations
- Infectious Diseases
- Infectious Diseases (other than STDs)
- Malaria
- Maternal Child Health (incl. Reproductive Health)
- Metrics and Evaluation
- Pharmaceutical Science
- Research
Hay SI, Rao PC, Dolecek C, Day NPJ, Stergachis A, Lopez AD, Murray CJL. Measuring and mapping the global burden of antimicrobial resistance. BMC Medicine. 2018 Jun 4;16:78.
Oneko M, Vala A, Ruperez M, Macete E, Menendez C, Nakanabo-Diallo S, Kazienga A, Valea I, Calip G, Augusto O, Genton B, Njunju EM, Moore KA, d'Alessandro U, Nosten F, ter Kuile F; Stergachis A. First trimester artemisinin derivatives and quinine treatments and their association with adverse pregnancy outcomes in Africa and Asia: a meta-analysis of observational studies. PLOS Medicine. May 2 2017;14(5):e1002290.
Babigumira J, Lubinga SJ, Jenny AM, Larsen-Cooper E, Crawford J, Matemba C, Stergachis A. Impact of pharmacy worker training and deployment on access to essential medicines for children under five in Malawi: a cluster quasi-experimental evaluation. BMC Health Services Research 2017. 17(1):638.
Mann M, Mengistu A, Gaeseb J, Sagwa E, Mazibuko G, Babigumira JB, Garrison LP, Stergachis A. Active Surveillance versus Spontaneous Reporting for First-Line Antiretroviral Medicines in Namibia: A Cost Utility Analysis. Drug Saf. 2016 Sep;39(9):859-72.
Scholes D, Stergachis A, Heidrich FE, Andrilla H, Holmes KK, Stamm WE. Prevention of pelvic inflammatory disease by screening for cervical chlamydia infection. N Eng J Med 1996; 334:1362-6.
Dellicour S, Sevene E, McGready R, Tinto H, Mosha D, Mayando C, Rulisa S, Desai M, Ouma P, Oneko M, Vala A, Ruperez M, Macete E, Menendez C, Nakanabo-Diallo S, Kazienga A, Valea I, Calip G, Augusto O, Genton B, Njunju EM, Moore KA, d'Alessandro U, Nosten F, ter Kuile F; Stergachis A. First trimester artemisinin derivatives and quinine treatments and their association with adverse pregnancy outcomes in Africa and Asia: a meta-analysis of observational studies. PLOS Med. 2017 May 2;14(5):e1002290. PMID: 32268901.
Sobanjo-ter Meulen A, Munoz FM, Kaslow DC, Klugman KP, Omer SB, Vora P, Stergachis A. Maternal Interventions Vigilance Harmonization in Low- and Middle-Income Countries: Stakeholder Meeting Report; Amsterdam, May 1-2, 2018. Vaccine. 2019 May 6;37(20):2643-2650. PMID: 30955981.
Roth L. Bempong DK, Babigumira J, Banoo S, Cooke E, Jeffreys D, Kasonde L, Leufkens HGM, Lim J, Lumpkin M, Mahlangu G, Peeling R, Rees H, Ndomondo-Sigonda M, Stergachis A, Ward M, Nwokike J, Expanding Global Access to Essential Medicines: Investment Priorities for Sustainably Strengthening Medical Product Regulatory Systems. Globalization & Health. 2018 Nov 1;14(1):102. PMID: 30382856.
Babigumira J, Lubinga SJ, Jenny AM, Larsen-Cooper E, Crawford J, Matemba C, Stergachis A. Impact of pharmacy worker training and deployment on access to essential medicines for children under five in Malawi: a cluster quasi-experimental evaluation. BMC Health Services Research 2017. 17(1):638. PMID: 28893243.
Scholes D, Stergachis A, Heidrich FE, Andrilla H, Holmes KK, Stamm WE. Prevention of pelvic inflammatory disease by screening for cervical chlamydia infection. N Eng J Med 1996; 334:1362-6. PMID: 8614421.